0 Comments
0 Shares
1K Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Artificial Intelligence in Cancer Diagnostics Market Adoption Rising in Precision OncologyThe rapid evolution of AI oncology diagnostics, machine learning in healthcare, and deep learning cancer detection is reshaping the global healthcare landscape. Artificial intelligence is no longer an experimental tool; it has become a core component of modern cancer screening, diagnosis, and treatment planning. By analyzing medical imaging, pathology slides, and genomic...0 Comments 0 Shares 440 Views 0 Reviews
-
Breast Cancer Drug Market Expected to Expand with Rising Demand for Precision Oncology TreatmentsThe Breast Cancer Drug Market is expected to maintain steady growth as the global healthcare industry continues to prioritize long-term treatment strategies for breast cancer, particularly hormone receptor-positive (HR+) and HER2-negative disease. According to Future Market Insights (FMI), the market is projected to grow from USD 11.1 billion in 2026 to USD 12.4 billion by 2036, registering a...0 Comments 0 Shares 129 Views 0 Reviews
-
Breast Cancer Drug Market Expected to Expand with Rising Demand for Precision Oncology TreatmentsThe Breast Cancer Drug Market is expected to maintain steady growth as the global healthcare industry continues to prioritize long-term treatment strategies for breast cancer, particularly hormone receptor-positive (HR+) and HER2-negative disease. According to Future Market Insights (FMI), the market is projected to grow from USD 11.1 billion in 2026 to USD 12.4 billion by 2036, registering a...0 Comments 0 Shares 185 Views 0 Reviews
-
Cancer Biomarker Market Size, Precision Oncology and Early Diagnosis Trends Forecast to 2033Introduction The cancer biomarker market is experiencing rapid expansion as healthcare systems worldwide increasingly focus on early diagnosis, personalized treatment, and improved patient outcomes. Cancer biomarkers are biological molecules found in blood, tissue, or other body fluids that indicate the presence of cancer or the body’s response to it. These biomarkers play a crucial role...0 Comments 0 Shares 974 Views 0 Reviews
-
Cancer Diagnostics Market Demand Surges as Precision Oncology Gains MomentumCancer diagnostics remains a vital part of modern healthcare, supporting physicians in identifying cancer at early stages and enabling more informed treatment planning. As cancer cases continue to increase globally, hospitals, specialty clinics, and diagnostic laboratories are investing more in advanced screening and detection technologies. The ability to diagnose cancer accurately and...0 Comments 0 Shares 480 Views 0 Reviews
-
Cancer Treatment Drugs Market to Reach USD 359.83 Billion by 2032 Driven by Immunotherapy and Precision Oncology AdvancementsAccording to a report by Intel Market Research, the global cancer treatment drugs market was valued at USD 193.12 billion in 2024 and is projected to grow from USD 211.45 billion in 2025 to USD 359.83 billion by 2032, exhibiting a CAGR of 9.5% during the forecast period. The market is witnessing strong growth due to the rising global burden of cancer, increasing adoption of targeted therapies...0 Comments 0 Shares 568 Views 0 Reviews
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Comments 0 Shares 3K Views 0 Reviews
-
Global PSA Testing Market Expands at 12.0% CAGR Through 2035 Amid Growing Adoption of Precision Oncology and Early Detection TechnologiesAccording to the Latest Analysis by Future Market Insights (FMI), the Global Prostate-Specific Antigen (PSA) Testing Market is Expected to Witness Strong Growth Over the Next Decade, Driven by Rising Prostate Cancer Incidence, Advancements in AI-Driven Diagnostics, and Expanding Early Screening Programs The global Prostate-Specific Antigen (PSA) Testing Market is expected to grow significantly...0 Comments 0 Shares 368 Views 0 Reviews
-
Global Soft Tissue Sarcoma Market Forecast Highlights Opportunities in Precision Medicine and Immuno-OncologyGlobal Soft Tissue Sarcoma Market Set for Strong Growth Driven by Advancements in Oncology Therapeutics and Precision Medicine Global Soft Tissue Sarcoma Market Overview The Global Soft Tissue Sarcoma Market is witnessing steady growth as the healthcare industry continues to advance targeted cancer therapies, immuno-oncology treatments, and precision medicine for the management...0 Comments 0 Shares 138 Views 0 Reviews
-
HER2+ Gastric Cancer Market Advances with Growing Focus on Biomarker-Driven Therapies and Precision Oncology InnovationsAccording to the latest report published by Data Bridge Market Research, the HER2+ Gastric Cancer Market The global HER2+ Gastric Cancer market was valued at USD 1.32 billion in 2024 and is expected to reach USD 1.86 billion by 2032During the forecast period of 2025 to 2032 the market is sly to grow at a CAGR of 4.44% A large scale HER2+ Gastric Cancer Market research reports...0 Comments 0 Shares 470 Views 0 Reviews
-
HER2+ Gastric Cancer Market Advances with Targeted Therapy Innovations and Precision Oncology DevelopmentsAccording to the latest report published by Data Bridge Market Research, the HER2+ Gastric Cancer Market The global HER2+ Gastric Cancer market was valued at USD 1.32 billion in 2024 and is expected to reach USD 1.86 billion by 2032During the forecast period of 2025 to 2032 the market is sly to grow at a CAGR of 4.44% This global HER2+ Gastric Cancer Market report is a...0 Comments 0 Shares 488 Views 0 Reviews
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Comments 0 Shares 9K Views 0 Reviews
-
Cancer/Tumor Profiling Market Size Projected to Reach USD 23.4 Billion by 2032“According to a new report published by Introspective Market Research, Cancer/Tumor Profiling Market by Technology, Cancer Type, and Application, The Global Cancer/Tumor Profiling Market Size Was Valued at USD 11.08 Billion in 2024 and is Projected to Reach USD 23.4 Billion by 2032, Growing at a CAGR of 9.8%.” Cancer/Tumor Profiling refers to the comprehensive molecular examination...0 Comments 0 Shares 4K Views 0 Reviews
-
Chromatography Instrumentation Market Scope and Growth Analysis by 2034The Chromatography instrumentation has become an essential component in modern analytical science, enabling precise separation, identification, and quantification of chemical compounds across multiple industries. Its application spans pharmaceuticals, biotechnology, environmental monitoring, and food safety testing, where accuracy and compliance are critical. The increasing complexity of...0 Comments 0 Shares 2K Views 0 Reviews1
-
Epidermal Growth Factor Receptor Inhibitor Market Strategic Insights for Leading CompaniesThe global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...0 Comments 0 Shares 695 Views 0 Reviews
-
Hadron Therapy Market Outlook 2025–2031 | Emerging Cancer Treatment Innovations & 14.3% CAGRThe Hadron Therapy involves the use of particle accelerators to generate beams that can penetrate tumors and release energy at a specific depth. This controlled energy delivery makes it suitable for treating complex cancers. Hadron Therapy Market Overview The Hadron Therapy Market size is expected to reach US$ 4.97 Billion by 2031. The market is anticipated to register a CAGR of 14.3%...0 Comments 0 Shares 2K Views 0 Reviews
-
HDAC Inhibitor Market Outlook Across Oncology and Therapeutic ApplicationsThe global HDAC inhibitor market is gaining significant momentum as the healthcare industry continues to advance targeted therapies for cancer and other complex diseases. Histone deacetylase (HDAC) inhibitors are a class of compounds that regulate gene expression by altering chromatin structure, making them valuable in the treatment of various malignancies and epigenetic disorders. The...0 Comments 0 Shares 694 Views 0 Reviews
-
Histone Deacetylase Inhibitors Market Advances with Growing Epigenetic Research and Targeted Oncology TherapiesAccording to the latest report published by Data Bridge Market Research, the Histone Deacetylase Inhibitors Market The Global Histone Deacetylase Inhibitors Market was valued at USD 1.3 billion in 2024 and is expected to reach USD 2.3 billion by 2032, at a CAGR of 7.7% during the forecast period The reliable Histone Deacetylase Inhibitors Market research report includes a...0 Comments 0 Shares 340 Views 0 Reviews
-
North America Leads Clinical Trials Market With 50.7% Revenue ShareThe clinical trials market is witnessing strong momentum as pharmaceutical and biotechnology companies continue to increase investments in research and development to accelerate the discovery of advanced therapies. The global clinical trials market size was estimated at USD 89.0 billion in 2025 and is projected to reach USD 158.4 billion by 2033, growing at a CAGR of 7.7% from 2026 to 2033. The...0 Comments 0 Shares 697 Views 0 Reviews
-
Precision Oncology Creates Stronger Demand for Advanced Biomarker TestingThe cancer biomarkers market is entering a period of strong expansion as rising cancer cases, increasing emphasis on early diagnosis, and growing adoption of personalized treatment continue to reshape oncology care. According to Grand View Research, the market size was valued at USD 26.9 billion in 2025 and is projected to increase from USD 29.9 billion in 2026 to USD 65.3 billion by 2033,...0 Comments 0 Shares 79 Views 0 Reviews
-
Rising Oncology Advances Boost Bladder Cancer Market ValuePrecision medicine is revolutionizing bladder cancer management strategies.Personalized treatment plans based on genetic profiling improve effectiveness.This trend is expanding opportunities within both therapeutics and diagnostics segments. The Bladder Cancer Therapeutics and Diagnostics Market is projected to register a robust CAGR of 10.2% from 2025 to 2031, with market size expanding...0 Comments 0 Shares 8K Views 0 Reviews
More Results